Status:
RECRUITING
The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
Lead Sponsor:
Hubei Cancer Hospital
Conditions:
Cancer Patients
Eligibility:
All Genders
Brief Summary
The purpose of this non-interventional study is to collect data on the risk factors for acute radiation pneumonitis in patients with prior receipt of immune checkpoint inhibitors.
Detailed Description
1. Incidence of acute radiation pneumonitis (aRPs) in in patients with prior receipt of immune checkpoint inhibitors. 2. Risk factors (especially analysis of the dosimetric risk factor) which may affe...
Eligibility Criteria
Inclusion
- Pathologically or cytologically confirmed malignant tumor
- Cancer patients with previously received ICIs underwent thoracic intensity-modulated radiotherapy
Exclusion
- Cancer patients did not receive immunotherapy before thoracic intensity-modulated radiotherapy
- Non-thoracic radiotherapy patients
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05219851
Start Date
June 1 2022
End Date
October 31 2025
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hubei Cancer Hospital
Wuhan, Hubei, China, 430079